New computer model sets new precedent in drug discovery
Tuesday, November 18, 2014 - 12:20
in Biology & Nature
A major challenge faced by the pharmaceutical industry has been how to rationally design and select protein molecules to create effective biologic drug therapies while reducing unintended side effects - a challenge that has largely been addressed through costly guess-and-check experiments. Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University offer a new approach, in a study published today in Biophysical Journal.